Eli Lilly and [LLY] vs Insmed [INSM] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Eli Lilly and wins in 8 metrics, Insmed wins in 3 metrics, with 0 ties. Eli Lilly and appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Eli Lilly and Insmed Better
P/E Ratio (TTM) 66.67 N/A N/A
Price-to-Book Ratio 49.26 181.16 Eli Lilly and
Debt-to-Equity Ratio 243.61 1,316.96 Eli Lilly and
PEG Ratio 36.16 -23.34 Insmed
EV/EBITDA 35.04 -20.89 Insmed
Profit Margin 22.67% -265.93% Eli Lilly and
Operating Margin 42.49% -247.61% Eli Lilly and
EBITDA Margin 42.49% N/A N/A
Return on Equity 77.28% -320.20% Eli Lilly and
Return on Assets 16.45% -36.25% Eli Lilly and
Free Cash Flow $414.30M $-705.81M Eli Lilly and
Dividend Yield 0.66% 0.00% Eli Lilly and
1-Year Return -6.73% 54.46% Insmed
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Eli Lilly and vs Insmed Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Eli Lilly and vs Insmed Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...